Introduction: Telomeres, repetitive DNA sequences at chromosome ends, shorten with cell division, countered by telomerase. Short telomeres are linked to cardiovascular disease (CVD), alongside its risk factors like aging, hypertension, diabetes, obesity, inactivity, and smoking. Many studies have claimed the implication of telomere length (TL) in cardiac diseases. This study examined TL’s impact on heart conditions using quantitative fluorescence in situ hybridization (Q-FISH) technology. Methods: Thirteen CVD patients (nine men and four women) aged 30–70 years and aged-matched healthy participants from the BIOTEL population TL database, were included in the study. Each chromosome’s TL from peripheral blood cells was measured using metaphase Q-FISH. An independent sample t test was used to compare participants’ mean or median TL with various medical factors and habits. Results: The mean TL of whole and short telomeres in cardiac disease patients was lower compared to aged-matched healthy controls; however, there was no statistical significance due to the limited patient sample. The mean TL of short telomeres in cardiac disease patients showed a remarkable decline with advanced age. Accordingly, the mean TL of whole and short telomeres in patients with cardiac diseases showed a similar reduced trend. Conclusion: In our study, shorter TL was observed in cardiac disease patients compared to those of healthy controls by using metaphase Q-FISH. However, more cases need to be studied to elucidate the use of TL as a potential biomarker for the diagnosis of patients with CVD.

1.
de Lange
T
.
Shelterin: the protein complex that shapes and safeguards human telomeres
.
Genes Dev
.
2005
;
19
(
18
):
2100
10
.
2.
Zglinicki
T
,
Martin-Ruiz
C
.
Telomeres as biomarkers for ageing and age-related diseases
.
Curr Mol Med
.
2005
;
5
(
2
):
197
203
.
3.
Herrmann
M
,
Pusceddu
I
,
März
W
,
Herrmann
W
.
Telomere biology and age-related diseases
.
Clin Chem Lab Med
.
2018
;
56
(
8
):
1210
22
.
4.
Kakridonis
F
,
Pneumatikos
S
,
Vakonaki
E
,
Berdiaki
A
,
Tzatzarakis
M
,
Fragkiadaki
P
, et al
.
Telomere length as a predictive biomarker in osteoporosis (Review)
.
Biomed Rep
.
2023
;
19
(
5
):
87
.
5.
Fragkiadaki
P
,
Nikitovic
D
,
Kalliantasi
K
,
Sarandi
E
,
Thanasoula
M
,
Stivaktakis
P
, et al
.
Telomere length and telomerase activity in osteoporosis and osteoarthritis
.
Exp Ther Med
.
2020
;
19
(
3
):
1626
32
.
6.
Nikolouzakis
T
,
Vassilopoulou
L
,
Fragkiadaki
P
,
Mariolis Sapsakos
T
,
Papadakis
G
,
Spandidos
D
, et al
.
Improving diagnosis, prognosis and prediction by using biomarkers in CRC patients (Review)
.
Oncol Rep
.
2018
;
39
(
6
):
2455
72
.
7.
Vakonaki
E
,
Tsiminikaki
K
,
Plaitis
S
,
Fragkiadaki
P
,
Tsoukalas
D
,
Katsikantami
I
, et al
.
Common mental disorders and association with telomere length
.
Biomed Rep
.
2018
;
8
(
2
):
111
6
.
8.
Fragkiadaki
P
,
Kouvidi
E
,
Angelaki
A
,
Nikolopoulou
D
,
Vakonaki
E
,
Tsatsakis
A
.
Evaluation of telomere length and telomerase activity on predicting in vitro fertilization treatment outcomes
.
J Assist Reprod Genet
.
2024
;
41
(
6
):
1463
73
.
9.
Vasilopoulos
E
,
Fragkiadaki
P
,
Kalliora
C
,
Fragou
D
,
Docea
A
,
Vakonaki
E
, et al
.
The association of female and male infertility with telomere length (Review)
.
Int J Mol Med
.
2019
;
44
(
2
):
375
89
.
10.
WHO
.
Cardiovascular diseases [Internet]
. Health Topics.
2023
. [cited 10 Jun 2024] Available from: https://www.who.int/health-topics/cardiovascular-diseases#tab=tab_1
11.
Di Cesare
M
,
Perel
P
,
Taylor
S
,
Kabudula
C
,
Bixby
H
,
Gaziano
TA
, et al
.
The heart of the world
.
Glob Heart
.
2024
;
19
(
1
):
11
.
12.
Luengo-Fernandez
R
,
Walli-Attaei
M
,
Gray
A
,
Torbica
A
,
Maggioni
AP
,
Huculeci
R
, et al
.
Economic burden of cardiovascular diseases in the European Union: a population-based cost study
.
Eur Heart J
.
2023
;
44
(
45
):
4752
67
.
13.
Willeit
P
,
Willeit
J
,
Brandstätter
A
,
Ehrlenbach
S
,
Mayr
A
,
Gasperi
A
, et al
.
Cellular aging reflected by leukocyte telomere length predicts advanced atherosclerosis and cardiovascular disease risk
.
Arterioscler Thromb Vasc Biol
.
2010
;
30
(
8
):
1649
56
.
14.
Yegorov
YE
,
Poznyak
AV
,
Nikiforov
NG
,
Starodubova
AV
,
Orekhov
AN
.
Role of telomeres shortening in atherogenesis: an overview
.
Cells
.
2021
;
10
(
2
):
395
.
15.
Deng
Y
,
Li
Q
,
Zhou
F
,
Li
G
,
Liu
J
,
Lv
J
, et al
.
Telomere length and the risk of cardiovascular diseases: a Mendelian randomization study
.
Front Cardiovasc Med
.
2022
;
9
:
1012615
.
16.
Tsatsakis
A
,
Tsoukalas
D
,
Fragkiadaki
P
,
Vakonaki
E
,
Tzatzarakis
M
,
Sarandi
E
, et al
.
Developing BIOTEL: a semi-automated spreadsheet for estimating telomere length and biological age
.
Front Genet
.
2019
;
10
:
84
.
17.
Vakonaki
E
,
Tzatzarakis
M
,
Tsiminikaki
K
,
Nathena
D
,
Fragkiadaki
P
,
Kalliantasi
K
, et al
.
Effect of chronic and heavy drug abuse on biological aging
.
World Acad Sci J
.
2019
;
1
:
67
73
.
18.
McIlrath
J
,
Bouffler
SD
,
Samper
E
,
Cuthbert
A
,
Wojcik
A
,
Szumiel
I
, et al
.
Telomere length abnormalities in mammalian radiosensitive cells
.
Cancer Res
.
2001
;
61
(
3
):
912
5
.
19.
Benjamin
EJ
,
Virani
SS
,
Callaway
CW
,
Chamberlain
AM
,
Chang
AR
,
Cheng
S
, et al
.
Heart disease and stroke statistics—2018 update: a report from the American heart association
.
Circulation
.
2018
;
137
(
12
):
e67
492
.
20.
Yeh
J-K
,
Wang
C-Y
.
Telomeres and telomerase in cardiovascular diseases
.
Genes
.
2016
;
7
(
9
):
58
.
21.
Tan
XW
,
Fong
AYY
.
Telomere and telomerase biology in cardiovascular disease: a state-of-the-art review and outlook
. In:
Hwang
SS
, editor.
J Asian Pac Soc Cardiol
.
2023
. Vol.
Vol. 2
. p.
e46
.
22.
Shin
D-Y
,
Lim
KM
,
Park
HS
,
Kwon
S
,
Yoon
S-S
,
Lee
D-S
.
The importance of critically short telomere in myelodysplastic syndrome
.
Biomark Res
.
2022
;
10
(
1
):
79
.
23.
Gruber
H-J
,
Semeraro
MD
,
Renner
W
,
Herrmann
M
.
Telomeres and age-related diseases
.
Biomedicines
.
2021
;
9
(
10
):
1335
.
24.
Frati
G
,
Versaci
F
,
Sciarretta
S
.
A novel signalling mechanism regulating telomere length in cardiomyocytes
.
Cardiovasc Res
.
2021
;
117
(
1
):
13
4
.
25.
Doroschuk
NA
,
Postnov
AY
,
Doroschuk
AD
,
Ryzhkova
AI
,
Sinyov
VV
,
Sazonova
MD
, et al
.
An original biomarker for the risk of developing cardiovascular diseases and their complications: telomere length
.
Toxicol Rep
.
2021
;
8
:
499
504
.
26.
Svensson
J
,
Karlsson
MK
,
Ljunggren
Ö
,
Tivesten
Å
,
Mellström
D
,
Movérare-Skrtic
S
.
Leukocyte telomere length is not associated with mortality in older men
.
Exp Gerontol
.
2014
;
57
:
6
12
.
27.
De Meyer
T
,
Van daele
CM
,
De Buyzere
ML
,
Denil
S
,
De Bacquer
D
,
Segers
P
, et al
.
No shorter telomeres in subjects with a family history of cardiovascular disease in the asklepios study
.
Arterioscler Thromb Vasc Biol
.
2012
;
32
(
12
):
3076
81
.
28.
Russo
A
,
Palumbo
L
,
Fornengo
C
,
Di Gaetano
C
,
Ricceri
F
,
Guarrera
S
, et al
.
Telomere length variation in juvenile acute myocardial infarction
.
PLoS One
.
2012
;
7
(
11
):
e49206
.
29.
Weischer
M
,
Bojesen
SE
,
Cawthon
RM
,
Freiberg
JJ
,
Tybjærg-Hansen
A
,
Nordestgaard
BG
.
Short telomere length, myocardial infarction, ischemic heart disease, and early death
.
Arterioscler Thromb Vasc Biol
.
2012
;
32
(
3
):
822
9
.
30.
Starnino
L
,
Dupuis
G
,
Busque
L
,
Bourgoin
V
,
Dubé
M-P
,
Busseuil
D
, et al
.
The associations of hostility and defensiveness with telomere length are influenced by sex and health status
.
Biol Sex Differ
.
2021
;
12
(
1
):
2
.
31.
Lai
T-P
,
Wright
WE
,
Shay
JW
.
Comparison of telomere length measurement methods
.
Philos Trans R Soc B Biol Sci
.
2018
;
373
(
1741
):
20160451
.
32.
Dweck
A
,
Maitra
R
.
The advancement of telomere quantification methods
.
Mol Biol Rep
.
2021
;
48
:
5621
7
.
33.
Alonso-Pedrero
L
,
Ojeda-Rodríguez
A
,
Zalba
G
,
Razquin
C
,
Martínez-González
,
Bes-Rastrollo
M
, et al
.
Association between ideal cardiovascular health and telomere length in participants older than 55 years old from the SUN cohort
.
Rev Esp Cardiol
.
2022
;
75
(
4
):
308
15
.
34.
Haycock
PC
,
Heydon
EE
,
Kaptoge
S
,
Butterworth
AS
,
Thompson
A
,
Willeit
P
.
Leucocyte telomere length and risk of cardiovascular disease: systematic review and meta-analysis
.
BMJ
.
2014
;
349
:
g4227
.
35.
Theodoris
CV
,
Mourkioti
F
,
Huang
Y
,
Ranade
SS
,
Liu
L
,
Blau
HM
, et al
.
Long telomeres protect against age-dependent cardiac disease caused by NOTCH1 haploinsufficiency
.
J Clin Invest
.
2017
;
127
(
5
):
1683
8
.
36.
Hu
C
,
Zhang
X
,
Teng
T
,
Ma
Z-G
,
Tang
Q-Z
.
Cellular senescence in cardiovascular diseases: a systematic review
.
Aging Dis
.
2022
;
13
(
1
):
103
28
.
37.
Evangelou
K
,
Vasileiou
PVS
,
Papaspyropoulos
A
,
Hazapis
O
,
Petty
R
,
Demaria
M
, et al
.
Cellular senescence and cardiovascular diseases: moving to the “heart” of the problem
.
Physiol Rev
.
2023
;
103
(
1
):
609
47
.
38.
Doksani
Y
.
The response to DNA damage at telomeric repeats and its consequences for telomere function
.
Genes
.
2019
;
10
(
4
):
318
.
39.
Schuck
PL
,
Ackerson
SM
,
Stewart
JA
.
Telomere biology
. In:
Encycl cell biol
.
Elsevier
;
2023
; p.
523
31
.
40.
Fyhrquist
F
,
Saijonmaa
O
,
Strandberg
T
.
The roles of senescence and telomere shortening in cardiovascular disease
.
Nat Rev Cardiol
.
2013
;
10
(
5
):
274
83
.
41.
Baragetti
A
,
Palmen
J
,
Garlaschelli
K
,
Grigore
L
,
Pellegatta
F
,
Tragni
E
, et al
.
Telomere shortening over 6 years is associated with increased subclinical carotid vascular damage and worse cardiovascular prognosis in the general population
.
J Intern Med
.
2015
;
277
(
4
):
478
87
.
42.
De Vusser
K
,
Pieters
N
,
Janssen
B
,
Lerut
E
,
Kuypers
D
,
Jochmans
I
, et al
.
Telomere length, cardiovascular risk and arteriosclerosis in human kidneys: an observational cohort study
.
Aging
.
2015
;
7
(
10
):
766
75
.
43.
Scheller Madrid
A
,
Rode
L
,
Nordestgaard
BG
,
Bojesen
SE
.
Short telomere length and ischemic heart disease: observational and genetic studies in 290 022 individuals
.
Clin Chem
.
2016
;
62
(
8
):
1140
9
.
44.
Zee
RYL
,
Michaud
SE
,
Germer
S
,
Ridker
PM
.
Association of shorter mean telomere length with risk of incident myocardial infarction: a prospective, nested case–control approach
.
Clin Chim Acta
.
2009
;
403
(
1–2
):
139
41
.
45.
Shaik
M
,
Subrahmanyam
S
.
Analysis of telomere length in the coronary artery to determine the pathogenesis of coronary artery disease
.
J Adv Biotechnol Exp Ther
.
2018
;
1
(
3
):
72
.
46.
Gutierrez-Rodrigues
F
,
Santana-Lemos
BA
,
Scheucher
PS
,
Alves-Paiva
RM
,
Calado
RT
.
Direct comparison of flow-FISH and qPCR as diagnostic tests for telomere length measurement in humans
.
PLoS One
.
2014
;
9
(
11
):
e113747
.
You do not currently have access to this content.